Prevalence of Human T-Cell Leukemia Virus Types I and II in Switzerland

Journal of Medical Virology

Volumn 72, Issue 2, 2004, Pages 328-337

  Böni, Jürg ^a   Bisset, Leslie R ^a   Burckhardt, Johann J ^b,l   Joller Jemelka, Helen I ^c   Bürgisser, Philippe ^d,i   Perrin, Luc ^e,j   Gorgievski, Meri ^f,j   Erb, Peter ^f,i   Fierz, Walter ^g,i   Piffaretti, Jean Claude ^h,j   Schüpbach, Jörg ^a,k   Bachmann, S ⁱ   Battegay, M ⁱ   Bernasconi, E ⁱ   Bucher, H ⁱ   Cattacin, S ⁱ   Egger, M ⁱ   Fischer, M ⁱ   Flepp, M ⁱ   Francioli, P ^d   Furrer, H J ^j   Gunthard H ^j   Hirschel, B ^j   Kaiser, L ^j   Kind, C ^j   Klimkait, Th ^j   Ledergerber, B ^j   Lauper, U ^j   Opravil, M ^j   Pantaleo, G ^j   Rickenbach, M ^j   Rudin, C ^k   Speck, R ^k   Telenti, A ^k   Trkola, A ^k   Vernazza, P ^k   Weber, R ^k   Yerly, S ^k   more..

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Central Laboratory in Bern   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e UNIVERSITY HOSPITAL   (Switzerland)

^f UNIVERSITY OF BERN   (Switzerland)

^g Inst for Clin Microbiol/Immunol   (Switzerland)

^h Istituto Cantonale di Microbiologia   (Switzerland)

ⁱ Clinical and Laboratory Committee

^j Data Center

^k Scientific Board ^*

^l Burckhardt Healthcare Consulting   (Switzerland)

more..

Author keywords

Blood transfusion; HIV 1; HTLV I; HTLV II; Prevalence study; Switzerland

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CONTROLLED STUDY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NONHUMAN; ORGAN DONOR; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; POPULATION; SCREENING TEST; SERUM; SWITZERLAND; VIRUS CULTURE; VIRUS TRANSMISSION; WESTERN BLOTTING;

BLOOD DONORS; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HTLV-I INFECTIONS; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; LEUKOCYTES, MONONUCLEAR; POLYMERASE CHAIN REACTION; PREVALENCE; SEQUENCE ANALYSIS, DNA; SWITZERLAND; VIRUS CULTIVATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 9144261857     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10541     Document Type: Article

References (62)

1. Ades AE, Parker S, Walker J, Edginton M, Taylor GP, Weber JN. 2000. Human T cell leukaemia/lymphoma virus infection in pregnant women in the United Kingdom: Population study. BMJ 320:1497-1501.
2. Anonymous. 1996. Seroepidemiology of the human T-cell leukaemia/ lymphoma viruses in Europe. The HTLV European Research Network. J Acquir Immune Defic Syndr Hum Retrovirol 13:68-77.
3. Anonymous. 2002. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. J Postgrad Med 48:206-208.
4. Berger JR, Sabet A. 2002. Infectious myelopathies. Semin Neurol 22:133-142.
5. Böni J. 1996. PCR detection of HIV. Methods Mol Biol 50:93-107.
6. Boni J, Schupbach J. 1993. Sensitive and quantitative detection of PCR-amplified HIV-1 DNA products by an enzyme linked immunoassay following solution hybridization with two differently labelled oligonucleotide probes. Mol Cell Probes 7:361-371.
7. Busch MP, Switzer WM, Murphy EL, Thomson R, Heneine W. 2000. Absence of evidence of infection with divergent primate T-lymphotropic viruses in United States blood donors who have seroindeterminate HTLV test results. Transfusion 40:443-449.
8. Calabro ML, Luparello M, Grottola A, Del Mistro A, Fiore JR, Angarano G, Chieco-Bianchi L. 1993. Detection of human T lymphotropic virus type II/b in human immunodeficiency virus type 1-coinfected persons in southeastern Italy. J Infect Dis 168:1273-1277.
9. de Saussure P, Chofflon M, Pugin P, Bierens de Hahn D, Perrin L. 1991. HTLV-I/II in Switzerland: Apropos of 4 case reports. Schweiz Med Wochenschr 121:1761-1766.
10. Gallo RC. 2002. Human retroviruses after 20 years: A perspective from the past and prospects for their future control. Immunol Rev 185: 236-265.
11. Gao F, Yue L, White AT, Pappas PG, Barchue J, Hanson AP, Greene BM, Sharp PM, Shaw GM, Hahn BH. 1992. Human infection by genetically diverse SIVSM-related HIV-2 in west Africa. Nature 358:495-499.
12. Gao F, Bailes E, Robertson DL, Chen Y, Rodenburg CM, Michael SF, Cummins LB, Arthur LO, Peeters M, Shaw GM, Sharp PM, Hahn BH. 1999. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 397:436-441.
13. Gessain A, Mathieux R. 1995. HTLV-1 "indeterminate" Western blot patterns observed in sera from tropical regions: The situation revisited. J Acquir Immune Defic Syndr Hum Retrovirol 9:316-319.
14. Goubau P, Liu HF, De Lange GG, Vandamme AM, Desmyter J. 1993. HTLV-II seroprevalence in pygmies across Africa since 1970. AIDS Res Hum Retroviruses 9:709-713.
15. Haertle T, Carrera CJ, Wasson DB, Sowers LC, Richman DD, Carson DA. 1988. Metabolism and anti-human immunodeficiency virus-1 activity of 2-halo-2′,3′-dideoxyadenosine derivatives. J Biol Chem 263:5870-5875.
16. Hamers FF, Alix J, Semaille C, Pilkington H, Downs A. 2001. Surveillance of HIV/AIDS in Europe: Update at end 2000. Euro Surveill 6:84-85.
17. Hassig A. 1991. 50 Years of blood transfusion services of the Swiss Red Cross. Schweiz Med Wochenschr 121:156-159.
18. Hino S, Yamaguchi K, Katamine S, Sugiyama H, Amagasaki T, Kinoshita K, Yoshida Y, Doi H, Tsuji Y, Miyamoto T. 1985. Mother-to-child transmission of human T-cell leukemia virus type-I. Jpn J Cancer Res 76:474-480.
19. Hjelle B, Mills R, Swenson S, Mertz G, Key C, Allen S. 1991. Incidence of hairy cell leukemia, mycosis fungoides, and chronic lymphocytic leukemia in first known HTLV-II-endemic population. J Infect Dis 163:435-440.
20. Hjelle B, Cyrus S, Swenson SG. 1992. Evidence for sexual transmission of human T lymphotropic virus type II. Ann Intern Med 116:90-91.
21. Hollinger FB, Bremer JW, Myers LE, Gold JW, McQuay L. 1992. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. The NIH/ NIAID/DAIDS/ACTG Virology Laboratories. J Clin Microbiol 30: 1787-1794.
22. Kaplan JE, Osame M, Kubota H, Igata A, Nishitani H, Maeda Y, Khabbaz RF, Janssen RS. 1990. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr 3:1096-1101.
23. Khabbaz RF, Heneine W, Grindon A, Hartley TM, Shulman G, Kaplan J. 1992a. Indeterminate HTLV serologic results in U.S. blood donors: Are they due to HTLV-I or HTLV-II? J Acquir Immune Defic Syndr 5:400-404.
24. Khabbaz RF, Onorato IM, Cannon RO, Hartley TM, Roberts B, Hosein B, Kaplan JE. 1992b. Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med 326:375-380.
25. Kwok S, Lipka JJ, McKinney N, Kellogg DE, Poiesz B, Foung SK, Sninsky JJ. 1990. Low incidence of HTLV infections in random blood donors with indeterminate Western blot patterns. Transfusion 30:491-494.
26. Lal RB, Rudolph DL, Coligan JE, Brodine SK, Roberts CR. 1992. Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II. Blood 80:544-550.
27. Lal RB, Rudolph D, Alpers MP, Sulzer AJ, Shi YP, Lal AA. 1994. Immunologic cross-reactivity between structural proteins of human T-cell lymphotropic virus type I and the blood stage of Plasmodium falciparum. Clin Diagn Lab Immunol 1:5-10.
28. Lehky TJ, Flerlage N, Katz D, Houff S, Hall WH, Ishii K, Monken C, Dhib-Jalbut S, McFarland HF, Jacobson S. 1996. Human T-cell lymphotropic virus type II-associated myelopathy: Clinical and immunologic profiles. Ann Neurol 40:714-723.
29. Lin HC, Bodkin M, Lal RB, Rabson AB. 1995. Selective infection of human T-lymphotropic virus type 1 (HTLV-1)-infected cells by chimeric human immunodeficiency viruses containing HTLV-1 tax response elements in the long terminal repeat. J Virol 69:7216-7225.
30. Mager DL, Freeman JD. 1987. Human endogenous retrovirus like genome with type C pol sequences and gag sequences related to human T-cell lymphotropic viruses. J Virol 61:4060-4066.
31. Maloney EM, Biggar RJ, Neel JV, Taylor ME, Hahn BH, Shaw GM, Blattner WA. 1992. Endemic human T cell lymphotropic virus type II infection among isolated Brazilian Amerindians. J Infect Dis 166:100-107.
32. Manns A, Murphy EL, Wilks R, Haynes G, Figueroa JP, Hanchard B, Barnett M, Drummond J, Waters D, Cerney M, et al. 1991. Detection of early human T-cell lymphotropic virus type I antibody patterns during seroconversion among transfusion recipients. Blood 77:896-905.
33. Meertens L, Rigoulet J, Mauclere P, Van Beveren M, Chen GM, Diop O, Dubreuil G, Georges-Goubot MC, Berthier JL, Lewis J, Gessain A. 2001. Molecular and phylogenetic analyses of 16 novel simian T cell leukemia virus type 1 from Africa: Close relationship of STLV-1 from Allenopithecus nigroviridis to HTLV-1 subtype B strains. Virology 287:275-285.
34. Mortreux F, Gabet AS, Wattel E. 2003. Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo. Leukemia 17:26-38.
35. Mossman T. 1983. Rapid colorometric assay for cellular growth and survival: Application to proliferation and cytotoxicity assay. J Immunol Meth 65:55-63.
36. Okochi K, Sato H, Hinuma Y. 1984. A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: Seroconversion in recipients. Vox Sang 46:245-253.
37. Palker TJ, Singer KH, Vahlne A. 1996. Characterization of an antigen shared by human thymic epithelium and human T cell leukemia virus p19 Gag protein. J Acquir Immune Defic Syndr Hum Retrovirol 11:10-19.
38. Perl A, Rosenblatt JD, Chen IS, DiVincenzo JP, Bever R, Poiesz BJ, Abraham GN. 1989. Detection and cloning of new HTLV-related endogenous sequences in man. Nucleic Acids Res 17:6841-6854.
39. Poiesz B, Dube D, Dube S, Love J, Papsidero L, Uner A, Hutchinson R. 2000. HTLV-II-associated cutaneous T-cell lymphoma in a patient with HIV-1 infection. N Engl J Med 342:930-936.
40. Pyra H, Boni J, Schupbach J. 1994. Ultrasensitive retrovirus detection by a reverse transcriptase assay based on product enhancement. Proc Natl Acad Sci USA 91:1544-1548.
41. Sachs L. 1992. Anwendung statistischer methoden. Angewandte statistik, 7th edn. Berlin: Springer-Verlag. 439 p.
42. Saitou N, Nei M. 1987. The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol 4:406-425.
43. Salemi M, Vandamme AM, Gradozzi C, Van Laethem K, Cattaneo E, Taylor G, Casoli C, Goubau P, Desmyter J, Bertazzoni U. 1998. Evolutionary rate and genetic heterogeneity of human T-cell lymphotropic virus type II (HTLV-II) using isolates from European injecting drug users. J Mol Evol 46:602-611.
44. Salemi M, Lewis M, Egan JF, Hall WW, Desmyter J, Vandamme AM. 1999a. Different population dynamics of human T cell lymphotropic virus type II in intravenous drug users compared with endemically infected tribes. Proc Natl Acad Sci USA 96:13253-13258.
45. Salemi M, Vandamme AM, Desmyter J, Casoli C, Bertazzoni U. 1999b. The origin and evolution of human T-cell lymphotropic virus type II (HTLV-II) and the relationship with its replication strategy. Gene 234:11-21.
46. Schockmel GA, Yerly S, Perrin L. 1997. Detection of low HIV-1 RNA levels in plasma. J Acquir Immune Defic Syndr Hum Retrovirol 14:179-183.
47. Schupbach J. 2001. Induction/activation and detection of occult viral agents present in mammalian cells. Dev Biol (Basel) 106: 425-437.
48. Schupbach J, Baumgartner A, Tomasik Z. 1988. HTLV-1 in Switzerland: Low prevalence of specific antibodies in HIV risk groups, high prevalence of cross-reactive antibodies in normal blood donors. Int J Cancer 42:857-862.
49. Soriano V, Tor J, Ribera A, Clotel B, Muga R, Pauplana M, Fernandez JL, Martin J, Foz M. 1989. HIV-1, HIV-2, and HTLV-I infection in high-risk groups in Spain. AIDS 3:615-616.
50. Stuver SO, Tachibana N, Okayama A, Shioiri S, Tsunetoshi Y, Tsuda K, Mueller NE. 1993. Heterosexual transmission of human T cell leukemia/lymphoma virus type I among married couples in southwestern Japan: An initial report from the Miyazaki Cohort Study. J Infect Dis 167:57-65.
51. Sudre P, Rickenbach M, Taffe P, Janin P, Volkart AC, Francioli P. 2000. Clinical epidemiology and research on HIV infection in Switzerland: The Swiss HIV Cohort Study 1988-2000. Schweiz Med Wochenschr 130:1493-1500.
52. Tajima K. 1998. Worldwide distribution of HTLV. Jpn J Cancer Res 89:1.
53. Takahashi T, Takase H, Urano T, Sugita S, Miyata K, Miyata N, Mochizuki M. 2000. Clinical features of human T-lymphotropic virus type 1 uveitis: A long-term follow-up. Ocul Immunol Inflamm 8:235-241.
54. Taylor GP. 1996. The epidemiology of HTLV-I in Europe. J Acquir Immune Defic Syndr Hum Retrovirol 13(Suppl 1):S8-S14.
55. Taylor GP. 1999. The epidemiology and clinical impact of HTLV infections in Europe. AIDS Rev 1:195-204.
56. Thompson JD, Higgins DG, Gibson TJ. 1994. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673-4680.
57. Van Dooren S, Gotuzzo E, Salemi M, Watts D, Audenaert E, Duwe S, Ellerbrok H, Grassmann R, Hagelberg E, Desmyter J, Vandamme AM. 1998. Evidence for a post-Columbian introduction of human T-cell lymphotropic virus [type I] [corrected] in Latin America. J Gen Virol 79:2695-2708.
58. Van Dyke RB, Heneine W, Perrin ME, Rudolph D, Starszak E, Woods T, Switzer WM, Kaplan JE. 1995. Mother-to-child transmission of human T-lymphotropic virus type II. J Pediatr 127:924-928.
59. Vandamme AM, Van Laethem K, Liu HF, Van Brussel M, Delaporte E, de Castro Costa CM, Fleischer C, Taylor G, Bertazzoni U, Desmyter J, Goubau P. 1997. Use of a generic polymerase chain reaction assay detecting human T-lymphotropic virus (HTLV) types I, II and divergent simian strains in the evaluation of individuals with indeterminate HTLV serology. J Med Virol 52:1-7.
60. Vignoli C, De Lamballerie X, Zandotti C, De Chesse R, Tamalet C, De Micco P. 1995. High prevalence of human T-lymphotropic virus (HTLV) infection in pregnant women in southern France. Eur J Epidemiol 11:93-94.
61. Zack JA, Cann AJ, Lugo JP, Chen IS. 1988. HIV-1 production from infected peripheral blood T cells after HTLV-I induced mitogenic stimulation. Science 240:1026-1029.
62. Zucker-Franklin D. 2000. Non-HIV retroviral associations with rheumatic disease. Curr Rheumatol Rep 2:156-162.